|
|
||||||||
American Journal of Clinical Nutrition, Vol 34, 1379-1383, Copyright © 1981 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
RA Jacob, HH Sandstead, JM Munoz, LM Klevay and DB Milne
Whole body surface losses of zinc, copper, and iron were measured in 13 male volunteers who lived in a controlled environment for 4 to 9 months. For 88 daily samples, the mean losses for zinc, copper, and iron were 0.50, 0.34, and 0.33 mg/day (3.9, 26, and 2.1% of the mean dietary intakes, respectively). There was a large variance in metal losses with no significant differences in variance within-versus- between subjects or on the same-versus-different diets. The surface losses of zinc and iron increased the apparent dietary requirements determined by balance measurements only 5 and 3%, respectively, while the increase in copper requirement due to surface loss was 25 to 30%.
This article has been cited by other articles:
![]() |
L. B. Baker, J. R. Stofan, A. A. Hamilton, and C. A. Horswill Comparison of regional patch collection vs. whole body washdown for measuring sweat sodium and potassium loss during exercise J Appl Physiol, September 1, 2009; 107(3): 887 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C Lukaski Magnesium, zinc, and chromium nutriture and physical activity Am. J. Clinical Nutrition, August 1, 2000; 72(2): 585S - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Brewer, R. D. Dick, V. Johnson, Y. Wang, V. Yuzbasiyan-Gurkan, K. Kluin, J. K. Fink, and A. Aisen Treatment of Wilson's Disease With Ammonium Tetrathiomolybdate: I. Initial Therapy in 17 Neurologically Affected Patients Arch Neurol, June 1, 1994; 51(6): 545 - 554. [Abstract] [PDF] |
||||
![]() |
G. J. BREWER, G. M. HILL, A. S. PRASAD, Z. T. COSSACK, and P. RABBANI Oral Zinc Therapy for Wilson's Disease Ann Intern Med, September 1, 1983; 99(3): 314 - 320. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |